Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-recovery-mode-email-service.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-recovery-mode-email-service.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-meta-query.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-meta-query.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/l10n/class-wp-translation-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/l10n/class-wp-translation-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/default-filters.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/default-filters.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-duotone.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-duotone.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-user-query.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-user-query.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/script-loader.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/script-loader.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/media.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/media.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-http.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-http.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-application-passwords.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/class-wp-application-passwords.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-global-styles-revisions-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-global-styles-revisions-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-autosaves-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-autosaves-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-menu-items-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-menu-items-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-font-families-controller.php on line 1

Warning: Uninitialized string offset 0 in /srv/users/amstribuneusr12/apps/berlinverdict-aws/public/wp-includes/rest-api/endpoints/class-wp-rest-font-families-controller.php on line 1
Tavicare Provides FDA-Approved COVID-19 Monoclonal Antibody IV Therapy to High-Risk Patients in Maryland | Berlin Verdict

Tavicare Provides FDA-Approved COVID-19 Monoclonal Antibody IV Therapy to High-Risk Patients in Maryland

The initiative taken by the Maryland-based clinic reflects a strong commitment to saving lives and promoting healthy living.

Chevy Chase, MD, 13th July 2022, ZEXPRWIRE, The year 2021 saw various preventive measures for COVID-19, including vaccination, practicing social distancing such as staying six feet apart, wearing a mask in crowded areas and washing hands frequently. Tavicare, a leading healthcare provider in Chevy Chase now provides FDA-approved COVID-19 Monoclonal Antibody IV therapy to high-risk patients infected with COVID-19 in Maryland.

COVID-19 is caused by SARS-CoV-2, which causes mild to severe respiratory illness. The most common symptoms include fever, cough, sore throat, severe headache, shortness of breath and loss of taste or smell. It affects everyone differently; some develop moderate symptoms and recover without hospitalization.

However, some people are at greater risk for developing severe conditions, especially those who are not vaccinated or have weaker immune systems.

The Monoclonal Antibody IV therapy helps avoid the need for hospitalization. It is administered using IVs or a single-dose injection to patients diagnosed with the virus. In this therapy, COVID-19 antibodies help a person’s body fight off the infection.

Research indicates that the injection has a lower dosage than the infusion therapy.

Tavicare offers healthcare services that are effective and reliable solutions for various medical needs. From hormonal therapy to depression treatment, experts at Tavicare provide therapies to help improve their patients’ overall health and well-being.

When asked about this initiative, Tavicare founder, President, and CEO, Dr. Delara K. Tavakoli, shared: “With the initiative of monoclonal antibody treatment, we aim to help keep high-risk patients with COVID-19 out of the hospital. This is the need of the hour as we can see new variants emerging every other day. Anti-SARS-CoV-2 mAbs treatment should be started right after SARS-CoV-2 infection is confirmed by an antigen test or if a patient has symptoms for seven days.”

At Tavicare, It is administered properly and in a particular setting so that allergic reactions can be managed as soon as possible. Patients are monitored thoroughly throughout the infusion and even afterward for at least an hour.

About Tavicare

Tavicare is a functional care practice dedicated to helping individuals live their best life. Dr. Tavakoli and her highly-experienced medical staff offer personalized care and treatment for diseases like menopause, low libido, low testosterone, hyperthyroidism, depression, and cancer.

Media Contacts

Company Name: Tavicare Inc

Email: office@tavicare.com

Website: https://tavicare.com/

Phone number: (301) 917-3200

Business Hours: Mon – Fri 9:00am-5:00pm

Address: 5530 Wisconsin Ave., Ste. 1125, Chevy Chase, MD

Contact Form: https://tavicare.com/contact-tavicare/

The post Tavicare Provides FDA-Approved COVID-19 Monoclonal Antibody IV Therapy to High-Risk Patients in Maryland appeared first on Zex PR Wire.

Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact contact@binarynewsnetwork.com

News

Prompt Passport Services Revolutionizes Travel Experience With Expedited Passport Applications And Renewals

A reputable registered courier service provides swift and dependable passport renewal and application services, along with the convenience of passport delivery to your doorstep...

The Big Black Book of Business

WASHINGTON, December 16th, 2020, ZEXPRWIRE, My name is William Michael Cunningham and I am the author of The JOBS Act: Crowdfunding Guide to Small Businesses...

DLI-IT Group’s Streamlined HRM Solutions Drive Business Growth in the UAE

Dubai, UAE, 31st August 2022, ZEXPRWIRE, Today, businesses have to integrate technological solutions to keep up with the rapidly changing business landscape. The same applies...

New Zealand Visa For Latvia, Macanese, Luxembourg, Us, Malta Citizens

NEW ZEALAND VISA FOR LATVIAN CITIZENS The NZeTA was launched in July 2019, allowing eligible travelers to visit New Zealand for tourism, business, or transit...

Saudi Visa For Estonia, Greek, German, French, Finnish Citizens

SAUDI VISA FOR ESTONIAN CITIZENS Many Estonians prefer to visit Saudi Arabia. Visitors were drawn to the country for its cultural enrichment, architectural marvels, beautiful...

Bitcoin Cloud Mining Booms on Banking Crisis

The world’s largest cryptocurrency is up nearly 70% so far this year Grenville House, Hong Kong S.A.R., 22nd Mar 2023, King NewsWire – Bitcoin has...

Badoer Investment Ltd brings Port City’s largest investment to date

Dubai, United Arab Emirates, 18th Nov 2022 – A world-renowned company, Badoer Investment Ltd., has expressed interest in bringing more than $220,000,000 worth of...

A Tour of India, as Authentic as It Gets–Kinnari Birla Inks Her World of Green, White, and Orange

TEXAS, UNITED STATES, August 20, 2024 — “Namaste, welcome to India!” This is how the experience starts with Kinnari Birla’s latest book, set to...

Pegasys’ Native Token, Staking And Yield Farming Major Upgrades

EINDHOVEN, NETHERLANDS, June 6, 2022, Pegasys, the first and leading AMM on Syscoin’s NEVM, released major upgrades at the end of April: their native...